From January 1, 2023 to March 31, 2023, the company has repurchased 3,618,461 shares, representing 0.94% for $525.8 million. With this, the company has completed the repurchase of 5,099,847 shares, representing 1.32% for $711.82 million under the buyback announced on August 3, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125 USD | -0.47% | +15.77% | +25.69% |
03/05 | Jefferies Adjusts Price Target on Moderna to $155 From $125 | MT |
03/05 | Oppenheimer Adjusts Price Target on Moderna to $163 From $142 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B | |
+19.33% | 11.64B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Tranche Update on Moderna, Inc.'s Equity Buyback Plan announced on August 3, 2022.